ER-Poor and HER2-Positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients after Neoadjuvant Chemo-Trastuzumab Therapy

PURPOSE: The study was to estimate the likelihood of axillary downstaging and to identify the factors predicting a pathologically node negative status after neoadjuvant chemotherapy (NAC) with or without trastuzumab in HER2-positive breast cancer. METHODS: Patients with HER2-positive, stage IIa-IIIc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Li, Jian-wei, Mo, Miao, Yu, Ke-da, Chen, Can-ming, Hu, Zhen, Hou, Yi-feng, Di, Gen-hong, Wu, Jiong, Shen, Zhen-zhou, Shao, Zhi-ming, Liu, Guang-yu
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4263615/
https://ncbi.nlm.nih.gov/pubmed/25504233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0114646
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados